Toronto Dominion Bank’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
– Sell
-500
Closed -$93K – 1640
2018
Q4
$93K Buy
+500
New +$103K ﹤0.01% 1165

Other funds holding IDXX

Toronto Dominion Bank's IDXX Position: Q2 2026 in Review

Toronto Dominion Bank increased its Idexx Laboratories (IDXX) stake by 28% in Q2 2026, buying an estimated $3.8M and bringing the position to 30,923 shares worth $16.3M. The position accounts for 0.02% of the portfolio, ranked #554.

Toronto Dominion Bank first reported a position in IDXX in Q2 2016 and has held it in 41 quarters since. The position peaked at $37.9M in Q4 2021. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Toronto Dominion Bank held 30,923 shares of Idexx Laboratories worth $16.3M as of Q2 2026.
  • Toronto Dominion Bank bought 6,768 Idexx Laboratories shares in Q2 2026, an estimated $3.8M.
  • Idexx Laboratories made up 0.02% of Toronto Dominion Bank's portfolio in Q2 2026, its #554 holding.
  • Toronto Dominion Bank first reported a position in Idexx Laboratories in Q2 2016 and has held it in 41 quarters since.
  • Toronto Dominion Bank's Idexx Laboratories position peaked at $37.9M in Q4 2021.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.